The Long Legacy of COVID-19 Disability

The legacy of the COVID-19 pandemic persists. There exists a continuing need for long-term treatment and disability. While state benefit systems such as workers’ compensation have made an admirable attempt in many jurisdictions to provide benefits, a significant gap and non-uniform delivery of benefits continue to exist among jurisdictions. Federal efforts are expanding to provide necessary research and treatment protocol resources. 

Vaccines highly effective against hospitalization from Delta variant

An encouraging analysis by PHE shows for the first time that two doses of COVID-19 vaccines are highly effective against hospitalization from the Delta (B.1.617.2) variant. Unfortunately, those who aren’t vaccinated face increased risk. 

VA Podcast: Emerging from the Pandemic - New Guidelines are Out, Can We Trust Them?

Emerging from the Pandemic - New Guidelines are Out, Can We Trust Them? 

Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials

-100% protection against severe disease
-Final analysis in U.K. trial confirms 96% efficacy against original strain of COVID-19
-Efficacy against variants confirmed in U.K. and South Africa